Is a complete NGNE research report available?

No complete published report is available for Neurogene Inc. (NGNE) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

Neurogene Inc. (NGNE)

NASDAQ: NGNE · USD

$30.4

+3.43 (+12.7%)· Recorded snapshot

Market cap	608.7M
Net income (ttm)	-111.1M
EPS (ttm)	-$5.04
Shares out	20M
Volume	554,854
Beta	2.09

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -111.1M
EPS (ttm): -$5.04
Market cap: 608.7M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Trzymaj

Metric	Value
Amount currency	USD
CIK code	0001404644
Company name	Neurogene Inc.
Country	United States
Country code	US
CUSIP number	64135M105
Earnings date	2026-11-12
Earnings time	amc
Employees	131
Employees change	24
Employees growth	22.43%
Enterprise value	$391.7M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2026-06-30
First seen	2026-05-09
Fiscal year end	December
Founded	2003
In index	RUSSELL2000
Industry	Biotechnology
Is primary listing	Yes
Is SPAC	No
ISIN number	US64135M1053
Last 10-K release date	2026-03-24
Last earnings date	2026-08-11
Last refreshed	2026-10-28
Last stock split type	Never
Market cap	$608.7M
Market cap category	Small-Cap
Next earnings date	2026-11-12
Options	Yes
Price	$30.42
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-10-28
Symbol	NGNE
U.S. state	New York
Website	https://www.neurogene.com

Metric

Value

Amount currency

USD

CIK code

0001404644

Company name

Neurogene Inc.

Country

United States

Country code

CUSIP number

64135M105

Earnings date

2026-11-12

Earnings time

amc

Employees

131

Employees change

Employees growth

22.43%

Enterprise value

$391.7M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2026-06-30

First seen

2026-05-09

Fiscal year end

December

Founded

2003

In index

RUSSELL2000

Industry

Biotechnology

Is primary listing

Yes

Is SPAC

ISIN number

US64135M1053

Last 10-K release date

2026-03-24

Last earnings date

2026-08-11

Last refreshed

2026-10-28

Last stock split type

Never

Market cap

$608.7M

Market cap category

Small-Cap

Next earnings date

2026-11-12

Options

Yes

Price

$30.42

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-10-28

Symbol

NGNE

U.S. state

New York

Website

https://www.neurogene.com

Metric	Value
Earnings yield	-16.58%
FCF / EV yield	-22.67%
FCF yield	-14.52%
P/B ratio	1.97x
Price / tangible book value	2.78x
Sector forward P/E	23.56x
Sector P/E	50.08x

Metric

Value

Earnings yield

-16.58%

FCF / EV yield

-22.67%

FCF yield

-14.52%

P/B ratio

1.97x

Price / tangible book value

2.78x

Sector forward P/E

23.56x

Sector P/E

50.08x

Metric	Value
Profit per employee	$-848,168
ROA	-27.97%
ROCE	-54.4%
ROE	-45.32%
ROIC	-29.73%

Metric

Value

Profit per employee

$-848,168

ROA

-27.97%

ROCE

-54.4%

ROE

-45.32%

ROIC

-29.73%

Metric	Value
EPS growth years	3
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Capital expenditures	$-890,000
Depreciation and amortization	$3.2M
EBIT	$-121.2M
EBITDA	$-118M
EPS	$-5.04
FCF per share	$-4.38
Financing cash flow	$36.5M
Free cash flow	$-87.7M
Free cash flow minus SBC	$-105.9M
Gross profit	$-88.4M
Investing cash flow	$103.9M
Net borrowing	$-43,000
Net cash flow	$53.7M
Net income	$-111.1M
Operating cash flow minus SBC	$-105M
Operating income	$-121.2M
Stock-based compensation	$18.2M

Metric

Value

Capital expenditures

$-890,000

Depreciation and amortization

$3.2M

EBIT

$-121.2M

EBITDA

$-118M

EPS

$-5.04

FCF per share

$-4.38

Financing cash flow

$36.5M

Free cash flow

$-87.7M

Free cash flow minus SBC

$-105.9M

Gross profit

$-88.4M

Investing cash flow

$103.9M

Net borrowing

$-43,000

Net cash flow

$53.7M

Net income

$-111.1M

Operating cash flow minus SBC

$-105M

Operating income

$-121.2M

Stock-based compensation

$18.2M

Metric	Value
Book value per share	$13.72
Debt / equity	0.04
Interest coverage	-40,409
Long-term assets	$15.5M
Long-term liabilities	$5.7M
Net cash (debt)	$217M
Net cash / market cap	35.94%
Net cash growth	-17.65%
Net debt / equity	-1
Piotroski F-Score	1
Property, plant and equipment	$14M
Shareholders' equity	$217.1M
Tangible book value	$217.1M
Tangible book value per share	$13.72
Total assets	$244.4M
Total cash	$225.4M
Total debt	$8.3M
Total liabilities	$27.2M
WACC	15.52%

Metric

Value

Book value per share

$13.72

Debt / equity

0.04

Interest coverage

-40,409

Long-term assets

$15.5M

Long-term liabilities

$5.7M

Net cash (debt)

$217M

Net cash / market cap

35.94%

Net cash growth

-17.65%

Net debt / equity

-1

Piotroski F-Score

Property, plant and equipment

$14M

Shareholders' equity

$217.1M

Tangible book value

$217.1M

Tangible book value per share

$13.72

Total assets

$244.4M

Total cash

$225.4M

Total debt

$8.3M

Total liabilities

$27.2M

WACC

15.52%

Metric	Value
Current assets	$228.9M
Current liabilities	$21.5M
Current ratio	10.64
Net working capital	$-15M
Quick ratio	10.5
Working capital	$207.4M

Metric

Value

Current assets

$228.9M

Current liabilities

$21.5M

Current ratio

10.64

Net working capital

$-15M

Quick ratio

10.5

Working capital

$207.4M

Metric	Value
Buyback yield / dilution	-12.28%
Dividend yield	0%
Shareholder yield	-12.28%

Metric

Value

Buyback yield / dilution

-12.28%

Dividend yield

Shareholder yield

-12.28%

Metric	Value
150-day SMA	$30.48
1D price change	12.71%
1M price change	6.25%
1M total return	6.25%
1W price change	18.43%
1W total return	18.43%
1Y price change	-6.18%
1Y return CAGR	-6.18%
1Y total return	-6.18%
20-day SMA	$25.12
200-day SMA	$27.71
3M price change	-13.11%
3M total return	-13.11%
50-day SMA	$31.15
50-day SMA vs 200-day SMA	50over200
52-week high	$43.66
52-week high date	2026-07-09
52-week low	$15.93
52-week low date	2026-02-05
6M price change	11.2%
6M total return	11.2%
All-time high	$74.49
All-time high date	2024-11-11
All-time low	$6.88
All-time low date	2025-04-08
Average true range (ATR)	$2.37
Average volume	349.4K
Beta (1Y)	2.67
Beta (2Y)	3.15
Beta (5Y)	2.09
Change from 52-week high	-30.33%
Change from 52-week low	90.96%
Change from all-time high	-59.62%
Change from all-time low	337.53%
Change from open	15.89%
Day's gap	-2.74%
Dollar volume	$16.9M
High price	$30.84
Low price	$26.14
Monthly RSI	54.88
Open price	$26.25
Position in 52-week range	91.06%
Premarket change	0.3%
Premarket close	$26.99
Premarket price	$27.07
Previous close	$26.99
Price vs 150-day SMA	-1.32%
Price vs 20-day SMA	19.75%
Price vs 200-day SMA	8.54%
Price vs 50-day SMA	-3.43%
Relative volume	1.59
RSI	58.93
Sharpe ratio	0.26
Sortino ratio	0.47
Volume	554.9K
Weekly RSI	51.14
YTD price change	46.02%
YTD total return	46.02%

Metric

Value

150-day SMA

$30.48

1D price change

12.71%

1M price change

6.25%

1M total return

6.25%

1W price change

18.43%

1W total return

18.43%

1Y price change

-6.18%

1Y return CAGR

-6.18%

1Y total return

-6.18%

20-day SMA

$25.12

200-day SMA

$27.71

3M price change

-13.11%

3M total return

-13.11%

50-day SMA

$31.15

50-day SMA vs 200-day SMA

50over200

52-week high

$43.66

52-week high date

2026-07-09

52-week low

$15.93

52-week low date

2026-02-05

6M price change

11.2%

6M total return

11.2%

All-time high

$74.49

All-time high date

2024-11-11

All-time low

$6.88

All-time low date

2025-04-08

Average true range (ATR)

$2.37

Average volume

349.4K

Beta (1Y)

2.67

Beta (2Y)

3.15

Beta (5Y)

2.09

Change from 52-week high

-30.33%

Change from 52-week low

90.96%

Change from all-time high

-59.62%

Change from all-time low

337.53%

Change from open

15.89%

Day's gap

-2.74%

Dollar volume

$16.9M

High price

$30.84

Low price

$26.14

Monthly RSI

54.88

Open price

$26.25

Position in 52-week range

91.06%

Premarket change

0.3%

Premarket close

$26.99

Premarket price

$27.07

Previous close

$26.99

Price vs 150-day SMA

-1.32%

Price vs 20-day SMA

19.75%

Price vs 200-day SMA

8.54%

Price vs 50-day SMA

-3.43%

Relative volume

1.59

RSI

58.93

Sharpe ratio

0.26

Sortino ratio

0.47

Volume

554.9K

Weekly RSI

51.14

YTD price change

46.02%

YTD total return

46.02%

Metric	Value
Float	11.3M
Float percentage	56.47%
Shares change (QoQ)	1.1%
Shares change (YoY)	12.28%
Shares held by insiders	7.01%
Shares held by institutions	61%
Shares outstanding	20M
Short % of float	44.02%
Short % of shares	24.86%
Short ratio	16.1 days

Metric

Value

Float

11.3M

Float percentage

56.47%

Shares change (QoQ)

1.1%

Shares change (YoY)

12.28%

Shares held by insiders

7.01%

Shares held by institutions

61%

Shares outstanding

20M

Short % of float

44.02%

Short % of shares

24.86%

Short ratio

16.1 days

Neurogene Inc. (NGNE)

Price

Financial snapshot

Fair-value bridge

Latest news · NGNE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NGNE indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on NGNE

Frequently asked questions